Why regulatory approval is not a market-entry strategy
A practical look at the access decisions that sit between authorization and real adoption.
Discuss this topic ↗INSIGHTS
Practical perspectives on market access and healthcare market entry.
Short, decision-oriented insights for teams navigating Italy and European healthcare markets.
Five questions to answer before approaching the Italian market
The questions that can reveal reimbursement, regional and commercial risks before resources are committed.
Discuss this topic ↗From CE mark to hospital adoption: where access plans often fail
Why procurement, local value evidence and stakeholder sequencing matter as much as regulatory readiness.
Discuss this topic ↗